Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
Pipeling MR, West EE, Osborne CM, Whitlock AB, Dropulic LK, Willett MH, Forman M, Valsamakis A, Orens JB, Moller DR, Lechtzin N, Migueles SA, Connors M, McDyer JF.
Pipeling MR, et al. Among authors: valsamakis a.
J Immunol. 2008 Jul 1;181(1):546-56. doi: 10.4049/jimmunol.181.1.546.
J Immunol. 2008.
PMID: 18566421
Free PMC article.